About 12 million Americans are known as "dual eligibles" because they need both Medicare and Medicaid. A bipartisan bill offers hope to cut through the tangle of red tape that often ensnares them.
The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026. In the meantime, drugmakers are fighting the negotiations with lawsuits.
Medicare was supposed to cover the entire cost of his procedure. But the anesthesia provider failed to file its claims in a timely manner and billed the patient instead.
Medicare soon will start something it hasn't done in its 58-year history: Negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.
The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.
At least $1.1 billion was actually paid out in these schemes targeting elderly patients, high-risk and low-income pregnant women and HIV patients.
Some seniors got dozens of COVID tests they never ordered. Bad actors may have used seniors' Medicare information to improperly bill the federal government — and could do it again, investigators say.
The end-of-life benefit costs billions a year. A new approach aims to eliminate waste and weed out bad actors, while making the care more inviting to those who most need it.
Policymakers will need to patch the Social Security program by 2033 to avoid draconian cuts in benefits, a year earlier than had been predicted. A trust fund for Medicare will run out of cash by 2031.